Chimeric antigen receptor T-cell therapy for T-ALL and AML

• Wenwen Wei,
• Wenwen Wei,
• Dong Yang,
• Xi Chen,
• Dandan Liang,
• Liqun Zou,
• Xudong Zhao

Affiliations

Wenwen Wei

Laboratory of Animal Tumor Models, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China

Wenwen Wei

Department of Medical Oncology of Cancer Center, West China Hospital of Sichuan University, Chengdu, China

Dong Yang

Laboratory of Animal Tumor Models, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China

Xi Chen

Department of Radiotherapy, Cancer Center, West China Hospital of Sichuan University, Chengdu, China

Dandan Liang

Laboratory of Animal Tumor Models, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China

Liqun Zou

Department of Medical Oncology of Cancer Center, West China Hospital of Sichuan University, Chengdu, China

Xudong Zhao

Laboratory of Animal Tumor Models, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China